SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-022590
Filing Date
2021-01-29
Accepted
2021-01-29 16:01:23
Documents
5
Effectiveness Date
2021-01-29

Document Format Files

Seq Description Document Type Size
1 S-8 d244537ds8.htm S-8 79670
2 EX-5.1 d244537dex51.htm EX-5.1 4634
3 EX-23.1 d244537dex231.htm EX-23.1 1800
4 EX-99.3 d244537dex993.htm EX-99.3 115520
5 GRAPHIC g244537snap00015.jpg GRAPHIC 2983
  Complete submission text file 0001193125-21-022590.txt   206882
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-252557 | Film No.: 21571115
SIC: 2834 Pharmaceutical Preparations